Skip to Content

Notice

Office of the Director, National Institutes of Health; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Council of Councils.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended because the premature disclosure of other and the discussions would likely to significantly frustrate implementation of recommendations.

Name of Committee: Council of Councils.

Date: March 31-April 1, 2008.

Open: March 31, 2008, 8:15 a.m. to 3 p.m.

Agenda: Topics proposed for discussion are: Reports from OPASI Divisions, new concepts and current initiatives, an overview of private-public partnerships and the Foundation for the NIH, and Council Subcommittees and Working Groups.

Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892.

Closed: March 31, 2008, 3:15 p.m. to 5 p.m.

Agenda: To allow the Subcommittees to conduct confidential, preliminary discussions leading to the presentation of advice and recommendations to the overall Council.

Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892.

Open: April 1, 2008, 8:30 a.m. to 12 p.m.

Agenda: Continuation of CoC discussions.

Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892.

Contact Person: Elizabeth L. Wilder, PhD, Program Director, Division of Kidney, Urologic, and Hematologic Diseases, Two Democracy Plaza, MSC 5458, 6707 Democracy Boulevard, Room 623, Bethesda, MD 20892-5458, (301) 594-1409, wilderb@extra.niddk.nih.gov.

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Start Printed Page 13913Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)

Start Signature

Dated: March 5, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. E8-4924 Filed 3-13-08; 8:45 am]

BILLING CODE 4140-01-M